The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania

BACKGROUND. To provide data on the use of anti-cyclic citrullinated peptide antibody (anti-CCP) and other routinely used clinical parameters and to assess the impact of anti-CCP status on therapeutic decisions, an observational study was conducted in patients with rheumatoid arthritis (RA). METHODS....

Descripción completa

Detalles Bibliográficos
Autores principales: Stropuvienė, Sigita, Baranauskaitė, Asta, Bukauskienė, Loreta, Zaikauskienė, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lithuanian Academy of Sciences Publishers 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130926/
https://www.ncbi.nlm.nih.gov/pubmed/30210246
http://dx.doi.org/10.6001/actamedica.v25i2.3765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130926/
https://www.ncbi.nlm.nih.gov/pubmed/30210246
http://dx.doi.org/10.6001/actamedica.v25i2.3765

Ejemplares similares